213 related articles for article (PubMed ID: 32312805)
61. The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: an in vivo and in vitro study.
Ferraro L; Tomasini MC; Gessa GL; Bebe BW; Tanganelli S; Antonelli T
Cereb Cortex; 2001 Aug; 11(8):728-33. PubMed ID: 11459762
[TBL] [Abstract][Full Text] [Related]
62. Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure.
Hoffman AF; Oz M; Caulder T; Lupica CR
J Neurosci; 2003 Jun; 23(12):4815-20. PubMed ID: 12832502
[TBL] [Abstract][Full Text] [Related]
63. Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 increases glutamate uptake through overexpression of GLT1 and EAAC1 glutamate transporter subtypes in rat frontal cerebral cortex.
Castaldo P; Magi S; Gaetani S; Cassano T; Ferraro L; Antonelli T; Amoroso S; Cuomo V
Neuropharmacology; 2007 Sep; 53(3):369-78. PubMed ID: 17631920
[TBL] [Abstract][Full Text] [Related]
64. The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat.
Abalo R; Cabezos PA; Vera G; Fernández-Pujol R; Martín MI
Neurogastroenterol Motil; 2010 Jun; 22(6):694-e206. PubMed ID: 20132133
[TBL] [Abstract][Full Text] [Related]
65. Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids.
Diana M; Melis M; Gessa GL
Eur J Neurosci; 1998 Sep; 10(9):2825-30. PubMed ID: 9758152
[TBL] [Abstract][Full Text] [Related]
66. Effect of cannabinoids on platelet serotonin uptake.
Velenovská M; Fisar Z
Addict Biol; 2007 Jun; 12(2):158-66. PubMed ID: 17508987
[TBL] [Abstract][Full Text] [Related]
67. Gene expression signature in brain regions exposed to long-term psychosocial stress following acute challenge with cannabinoid drugs.
Tomas-Roig J; Havemann-Reinecke U
Psychoneuroendocrinology; 2019 Apr; 102():1-8. PubMed ID: 30476795
[TBL] [Abstract][Full Text] [Related]
68. Cannabinoid WIN-55,212-2 mesylate inhibits interleukin-1β induced matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human chondrocytes.
Dunn SL; Wilkinson JM; Crawford A; Le Maitre CL; Bunning RA
Osteoarthritis Cartilage; 2014 Jan; 22(1):133-44. PubMed ID: 24211233
[TBL] [Abstract][Full Text] [Related]
69. Chronic pubertal cannabinoid treatment as a behavioural model for aspects of schizophrenia: effects of the atypical antipsychotic quetiapine.
Leweke FM; Schneider M
Int J Neuropsychopharmacol; 2011 Feb; 14(1):43-51. PubMed ID: 20678304
[TBL] [Abstract][Full Text] [Related]
70. Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment.
Wegener N; Koch M
Brain Res; 2009 Feb; 1253():81-91. PubMed ID: 19094973
[TBL] [Abstract][Full Text] [Related]
71. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors.
Abalo R; Cabezos PA; Vera G; López-Miranda V; Herradón E; Martín-Fontelles MI
Neurogastroenterol Motil; 2011 May; 23(5):457-67, e177. PubMed ID: 21303434
[TBL] [Abstract][Full Text] [Related]
72. The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro.
Luca T; Di Benedetto G; Scuderi MR; Palumbo M; Clementi S; Bernardini R; Cantarella G
Eur J Pharmacol; 2009 Aug; 616(1-3):16-21. PubMed ID: 19539619
[TBL] [Abstract][Full Text] [Related]
73. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
Zhang CQ; Wu HJ; Wang SY; Yin S; Lu XJ; Miao Y; Wang XH; Yang XL; Wang Z
Neuroscience; 2013 Dec; 253():183-93. PubMed ID: 24013008
[TBL] [Abstract][Full Text] [Related]
74. Activation of the cannabinoid system in the nucleus accumbens affects effort-based decision making.
Fatahi Z; Haghparast A
Pharmacol Biochem Behav; 2018 Feb; 165():29-35. PubMed ID: 29291421
[TBL] [Abstract][Full Text] [Related]
75. The cannabinoid WIN 55,212-2-mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav 2.2 channels.
Koch M; Kreutz S; Böttger C; Grabiec U; Ghadban C; Korf HW; Dehghani F
Hippocampus; 2011 May; 21(5):554-64. PubMed ID: 20135626
[TBL] [Abstract][Full Text] [Related]
76. Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids.
Hoffman AF; Lupica CR
J Neurophysiol; 2001 Jan; 85(1):72-83. PubMed ID: 11152707
[TBL] [Abstract][Full Text] [Related]
77. The kappa-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212-2), abstinence-induced withdrawal in planarians: an instance of 'pharmacologic congruence'.
Raffa RB; Stagliano GW; Ross G; Powell JA; Phillips AG; Ding Z; Rawls SM
Brain Res; 2008 Feb; 1193():51-6. PubMed ID: 18178175
[TBL] [Abstract][Full Text] [Related]
78. Differential effects of acute cannabinoid drug treatment, mediated by CB1 receptors, on the in vivo activity of tyrosine and tryptophan hydroxylase in the rat brain.
Moranta D; Esteban S; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 2004 May; 369(5):516-24. PubMed ID: 15064921
[TBL] [Abstract][Full Text] [Related]
79. Effects of the cannabinoid receptor agonist WIN 55,212-2 on operant behavior and locomotor activity in rats.
Drews E; Schneider M; Koch M
Pharmacol Biochem Behav; 2005 Jan; 80(1):145-50. PubMed ID: 15652390
[TBL] [Abstract][Full Text] [Related]
80. Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain.
Sim LJ; Hampson RE; Deadwyler SA; Childers SR
J Neurosci; 1996 Dec; 16(24):8057-66. PubMed ID: 8987831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
